Children's Research Institute

Children's Research Institute, doing business as Childrens Research Institute, is a tax-exempt nonprofit pediatric research organization based in Washington, D.C., and operates as the research subsidiary of Children's National Medical Center. The organization acts primarily as a federal grant recipient, conducting investigator-initiated and translational biomedical research across neuroscience, oncology, immunology, rare diseases, cardiac and pulmonary medicine, and behavioral health. Children's Research Institute competes in full-and-open federal grant competitions without set-aside designations, addressing gaps in pediatric health through a portfolio weighted heavily toward National Institutes of Health funding.

Children's Research Institute's recent award activity (past five years) shows 701 federal grants and sub-awards, with 63% prime recipient status and 37% sub-recipient participation. The organization received an average of 71 awards annually from 2022 to 2026. The top customer agencies by both award count and potential value are NIH institutes: the National Institute of Child Health and Human Development (68 awards, $12.5 million combined potential value), the National Heart, Lung, and Blood Institute (64 awards, $8.5 million), and the National Institute of Neurological Disorders and Stroke (54 awards). Together, these three institutes and the National Cancer Institute account for approximately 46% of total award count. The distribution of funding reflects the institute's research focus: NICHD and NHLBI collectively anchor 82% of combined potential value across the portfolio, with neurodevelopmental, cardiac, and pulmonary research commanding the largest dollar shares.

Recent prime grant work exemplifies the portfolio scope: a $1.818 million NHLBI Project Grant on postnatal hypoxemia and cardiac maturation in pediatric congenital heart disease (July 2026), a $794.7 thousand NICHD award for maternal depression and fetal brain structure research (FABMOMS study, June 2026), a $648.2 thousand NIAAA grant on fetal alcohol spectrum disorder neurocognitive mechanisms (June 2026), and a $616.7 thousand Defense Health Agency grant designing adoptive immunotherapy for high-risk pediatric medulloblastoma (August 2024). The institute also holds significant sub-recipient positions under prime grantees including Harvard (PHACS RISE HIV outcomes study), University of Pittsburgh (traumatic injury resuscitation trial), Children's Hospital of Philadelphia (autism longitudinal studies, leukodystrophy consortia), Baylor College of Medicine (Brittle Bone Disorders Consortium, organic acidemias research), and Emory University (sickle cell and Ebola training research).

Federal award concentration reflects Children's Research Institute's mission focus on pediatric and maternal-fetal neurobiology. Fifty-five distinct federal customer agencies are represented, but NIH institutes dominate: the top five NIH institutes (NICHD, NHLBI, NINDS, NCI, NIDDK) collectively account for 93% of award count in the source data. NICHD alone represents 68 awards, signaling deep integration with child development research priorities. Recent awards from the National Institute of Mental Health ($654 thousand on adolescent amygdala social circuitry, June 2026; $498.4 thousand on transcranial direct current stimulation response prediction, April 2025) and the National Institute on Alcohol Abuse and Alcoholism underscore strength in behavioral neuroscience and developmental psychiatry. Non-NIH funding appears through the Defense Health Agency (two awards on DMD therapy and medulloblastoma immunotherapy totaling $777.7 thousand and $616.7 thousand, respectively), the National Science Foundation (I-CORPS device translation, $500 thousand), and the Institute of Education Sciences (ADHD longitudinal study, $861.6 thousand). Fifty-five awards face ultimate completion within the next 24 months (combined potential value $4.1 million), representing recompete opportunities across developmental neuroscience, rare disease, and cardiac research portfolios.

Service Contract Inventory data shows limited federal service contract reporting: 13 total SCI records (2 as prime, 11 as subcontractor) spanning FY2022–FY2025. Prime SCI invoicing appears dormant at $0 reported, while sub-contractor SCI hours grew from 8.1 FTEs in FY2022 to 18.2 in FY2025, suggesting Children's Research Institute staff delivering services embedded on larger research cooperative agreements or clinical trials rather than standalone service contracts. This posture aligns with the organization's identity as a research institute: the award footprint is dominated by research grants (R01, R03, K-series mentorship, project grants, cooperative agreements) rather than service delivery contracts. The SCI-reportable hourly rate posture yields zero values, consistent with research grant economics where FTE deliverables are embedded in fixed-price or progressive-funding award structures rather than time-and-materials billable hours.

Teaming reflects Children's Research Institute's role as both independent research entity and component of the broader Children's National Health System. As prime recipient, the organization leads investigator-initiated NIH research, with sub-awardee relationships flowing to academic partners (George Washington University, University of Pittsburgh, Yale, Stanford, Columbia, Vanderbilt, Northwestern, Baylor, University of Wisconsin, UC Davis, UC Irvine) and clinical research networks (PECARN, Children's Oncology Group, Rare Disease Clinical Research Networks). As sub-recipient, the institute contributes clinical site enrollment, behavioral data collection, neuroimaging expertise, and mechanistic assay support to multi-site trials and consortia. The parent structure—Children's National Medical Center—provides clinical infrastructure (patient recruitment, IRB administration, biospecimen collection, clinical trial support) that differentiates the research institute's competitive position in pediatric research networks. Cincinnati Children's Hospital Medical Center serves as a sub-recipient partner on the Department of Education IES award for ADHD longitudinal research, signaling collaborative multi-site epidemiological and intervention science.